These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20696914)

  • 1. Defective feedback regulation of NF-kappaB underlies Sjogren's syndrome in mice with mutated kappaB enhancers of the IkappaBalpha promoter.
    Peng B; Ling J; Lee AJ; Wang Z; Chang Z; Jin W; Kang Y; Zhang R; Shim D; Wang H; Fleming JB; Zheng H; Sun SC; Chiao PJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15193-8. PubMed ID: 20696914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered IκBα expression promotes NF-κB activation in monocytes from primary Sjögren's syndrome patients.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Pathology; 2012 Oct; 44(6):557-61. PubMed ID: 22935973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
    Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
    J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; De Lucro R; D'Amore M
    J Mol Histol; 2013 Aug; 44(4):447-54. PubMed ID: 23377923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and Systemic IKKε and NF-κB Signaling Associated with Sjögren's Syndrome Immunopathogenesis.
    Chen W; Lin J; Cao H; Xu D; Xu B; Xu L; Yue L; Sun C; Wu G; Qian W
    J Immunol Res; 2015; 2015():534648. PubMed ID: 26380323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
    Sun JL; Zhang HZ; Liu SY; Lian CF; Chen ZL; Shao TH; Zhang S; Zhao LL; He CM; Wang M; Zhang W; Chen H; Zhang FC
    Ann Rheum Dis; 2020 Apr; 79(4):518-524. PubMed ID: 32114510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
    Lisi S; Sisto M; Lofrumento DD; D'Amore M
    Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xinfeng Capsule reduces hypercoagulative state in patients with Sjogren's syndrome by inhibiting miR-155/SOCS1/NF-κB signaling pathway].
    Zhu F; Liu J; Wang G; Fang L; Zhang P; Tan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1366-1371. PubMed ID: 27667464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
    Gilboa-Geffen A; Wolf Y; Hanin G; Melamed-Book N; Pick M; Bennett ER; Greenberg DS; Lester S; Rischmueller M; Soreq H
    PLoS One; 2011; 6(12):e28727. PubMed ID: 22174879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
    Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
    Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
    Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
    Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.
    Zhang NN; Sun QS; Chen Z; Liu F; Jiang YY
    Mol Cell Biochem; 2013 Jan; 372(1-2):57-64. PubMed ID: 23054188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren's syndrome (pSS) via suppressing NF-κb signaling pathway.
    Zhu H; Zheng J; Zhou Y; Wu T; Zhu T
    Mol Cell Biochem; 2021 May; 476(5):2029-2037. PubMed ID: 33512636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter.
    Algarté M; Kwon H; Génin P; Hiscott J
    Mol Cell Biol; 1999 Sep; 19(9):6140-53. PubMed ID: 10454561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-34a promotes mitochondrial pathway of apoptosis in human salivary gland epithelial cells by activating NF-κB signaling.
    He F; Yu J; Ma S; Zhao W; Wang Q; He H; Zhang M; Wang J; Lu Z
    Arch Biochem Biophys; 2024 Aug; 758():110063. PubMed ID: 38880321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer.
    Ren X; Chen C; Luo Y; Liu M; Li Y; Zheng S; Ye H; Fu Z; Li M; Li Z; Chen R
    Mol Cancer; 2020 Feb; 19(1):35. PubMed ID: 32085715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of clinical factors, focus score, lymphocyte type and NF-κB pathway in Sjögren's syndrome.
    Ono J; Toya S; Ogura I; Okada Y
    Odontology; 2023 Jan; 111(1):207-216. PubMed ID: 35915313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
    Neuhöfer P; Liang S; Einwächter H; Schwerdtfeger C; Wartmann T; Treiber M; Zhang H; Schulz HU; Dlubatz K; Lesina M; Diakopoulos KN; Wörmann S; Halangk W; Witt H; Schmid RM; Algül H
    Gastroenterology; 2013 Jan; 144(1):192-201. PubMed ID: 23041330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.